Safety of parenteral third-generation cephalosporins
- 1 April 1990
- journal article
- review article
- Published by Elsevier in The American Journal of Medicine
- Vol. 88 (4) , S38-S44
- https://doi.org/10.1016/0002-9343(90)90326-9
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Impaired hemostasis caused by beta-lactam antibioticsThe American Journal of Surgery, 1988
- Enhanced Bleeding With Cefoxitin or MoxalactamArchives of internal medicine (1960), 1986
- Alteration of hemostasis associated with cefoperazone treatmentInfection, 1986
- Comparative toxicities of third-generation cephalosporinsThe American Journal of Medicine, 1985
- Hvpoprothrombinemia caused by cephalosporinsJournal of Antimicrobial Chemotherapy, 1985
- Production of Menaquinones by Intestinal AnaerobesThe Journal of Infectious Diseases, 1984
- Vitamin K–Dependent ProteinsNew England Journal of Medicine, 1984
- HYPOPROTHROMBINAEMIC BLEEDING ASSOCIATED WITH CEFTRIAXONEThe Lancet, 1983
- Effects of Moxalactam on Blood Coagulation and Platelet functionClinical Infectious Diseases, 1982
- Adverse effects of third-generation cephalosporinsJournal of Antimicrobial Chemotherapy, 1982